JB/CALL/BAYER/40/0.1/20.06.25 | Delayed Swiss Exchange 11:20:00 2024-05-16 EDT | ||
| 0.11 CHF | -15.38% |
|
| 3 months | -15.38% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BAYER AG
| Date | Price | Change |
|---|---|---|
| 24-05-16 | 0.11 | -15.38% |
| 24-05-15 | 0.13 | -7.14% |
| 24-05-14 | 0.14 | -6.67% |
| 24-05-13 | 0.15 | +7.14% |
Delayed Quote Swiss Exchange
Last update May 16, 2024 at 11:20 am
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | BAYER AG |
| Issuer | Bank Julius Bär |
| BAYAJB | |
| ISIN | CH1317200454 |
| Date issued | 2024-01-12 |
| Strike | 40 € |
| Maturity | 2025-06-20 (397 Days) |
| Parity | 10 : 1 |
| Emission price | 0.25 CHF |
| Emission volume | N/A |
| Settlement | both |
| Currency | CHF |
Technical Indicators
| Highest since issue | 0.23 CHF |
|---|---|
| Lowest since issue | 0.08 CHF |
| Spread | 0.01 CHF |
| Spread % | 9.09% |
Company Profile
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12.7%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Sector
-
Consensus: Bayer AG
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
28.58
EUR
Average target price
36.9
EUR
Spread / Average Target
+29.13%
- Stock Market
- Warrants
- BAYAJB Warrant
